Get the Stockscreener App
20.38
5.91%
-1.28
Pre-market:
21.13
0.75
+3.68%
Nanobiotix Adr stock is traded at $20.38, with a volume of 36,614.
It is down -5.91% in the last 24 hours and down -16.88% over the past month.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
See More
Previous Close:
$21.66
Open:
$21.21
24h Volume:
36,614
Relative Volume:
0.43
Market Cap:
$977.08M
Revenue:
$27,600
Net Income/Loss:
$-36.04M
P/E Ratio:
-25.58
EPS:
-0.7968
Net Cash Flow:
$-1.66M
1W Performance:
+0.54%
1M Performance:
-16.88%
6M Performance:
+432.11%
1Y Performance:
+400.92%
1-Day Range:
$20.32
$21.68
1-Week Range:
$19.90
$23.55
52-Week Range:
$2.76
$30.35
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
20.38 | 1.04B | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Guggenheim | Buy |
| Dec-08-23 | Initiated | Leerink Partners | Outperform |
| Jan-06-21 | Initiated | Evercore ISI | Outperform |
Nanobiotix Adr Stock (NBTX) Latest News
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - MSN
Nanobiotix (NASDAQ:NBTX) Shares Gap UpWhat's Next? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownTime to Sell? - MarketBeat
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M - MSN
Nanobiotix (NASDAQ:NBTX) Stock Price Up 10.3%Still a Buy? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Declines By 60.7% - MarketBeat
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - MSN
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - NewsBreak: Local News & Alerts
Wayfair, Qorvo, Celestica, United Parcel Service,… - inkl
Carter's, Newmont Corporation And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket - inkl
Nanobiotix (NASDAQ:NBTX) Shares Down 4.6%Time to Sell? - MarketBeat
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Sees Large Growth in Short Interest - MarketBeat
Karooooo Posts Downbeat Earnings, Joins ASP Isotopes And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre Market Movers: NBTX, IMTX, QNRX See Big Swings - RTTNews
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - inkl
Nanobiotix (NASDAQ:NBTX) Shares Down 12%Should You Sell? - MarketBeat
Weiss Ratings Reiterates "Sell (D-)" Rating for Nanobiotix (NASDAQ:NBTX) - MarketBeat
This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan? - Barchart.com
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
FY2027 EPS Estimates for Nanobiotix Boosted by HC Wainwright - Defense World
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - inkl
Top 2 Health Care Stocks That May Keep You Up At Night This Month - inkl
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Reaches New 1-Year HighHere's Why - MarketBeat
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC - GlobeNewswire Inc.
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Hits New 52-Week HighHere's Why - MarketBeat
Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Short Interest Up 23.7% in August - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 11.8% HigherTime to Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Up 5.7%What's Next? - MarketBeat
Nanobiotix announces new results from JNJ-1900 study - TipRanks
Nanobiotix Adr Stock (NBTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):